No abstract available
Keywords:
S1P modulators; Sphingolipids; gut damage; inflammatory bowel disease; lymphocyte trafficking.
MeSH terms
-
Animals
-
Antibodies, Monoclonal / therapeutic use*
-
Colitis, Ulcerative / immunology
-
Colitis, Ulcerative / therapy*
-
Disease Models, Animal
-
Humans
-
Mesalamine / therapeutic use
-
Mice
-
Molecular Targeted Therapy
-
Receptors, Lysosphingolipid / immunology
-
Receptors, Lysosphingolipid / metabolism*
-
Signal Transduction
-
Steroids / therapeutic use
-
Tumor Necrosis Factor-alpha / immunology
Substances
-
Antibodies, Monoclonal
-
Receptors, Lysosphingolipid
-
Steroids
-
Tumor Necrosis Factor-alpha
-
Mesalamine